Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. 2004

Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
Division of Neuropsychiatry, Department of Psychiatry, Stanley Center for Experimental Therapeutics in Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA.

Auditory evoked potentials have been used in a variety of animal models to assess information-processing impairments in schizophrenia. Previous mouse models have primarily employed a paired click paradigm to assess the transient measures of auditory gating. The current study uses stimulus trains at varied interstimulus intervals (ISI) between 0.25 and 8 s in mice to assess the effects of chronic olanzapine and haloperidol on auditory processing. Data indicate that olanzapine increases the amplitude of the N40, P80, and P20/N40 components of the auditory evoked potential, whereas haloperidol had no such effect. The ISI paradigm also allowed for an evaluation of several components of the mouse evoked potential to assess those that display response properties similar to the human P50 and N100. Data suggest that the mouse N40 displays an ISI response relationship that shares characteristics with the human N100, whereas the P20 appears more consistent with the human P50 across the ISI range evaluated in this task. This study suggests that olanzapine may help improve N100 impairments seen in schizophrenia, while haloperidol does not.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005072 Evoked Potentials, Auditory The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS. Auditory Evoked Potentials,Auditory Evoked Response,Auditory Evoked Potential,Auditory Evoked Responses,Evoked Potential, Auditory,Evoked Response, Auditory,Evoked Responses, Auditory,Potentials, Auditory Evoked
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D000077152 Olanzapine A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,LY 170053,LY-170052,Olanzapine Pamoate,Zolafren,Zyprexa,LY 170052,LY170052
D000161 Acoustic Stimulation Use of sound to elicit a response in the nervous system. Auditory Stimulation,Stimulation, Acoustic,Stimulation, Auditory
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds

Related Publications

Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
December 2001, Journal of psychopharmacology (Oxford, England),
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
January 1976, Audiology : official organ of the International Society of Audiology,
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
June 2004, Journal of the American Academy of Audiology,
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
October 2009, Journal of the American Academy of Audiology,
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
December 2004, Neuroreport,
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
November 2008, Journal of psychopharmacology (Oxford, England),
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
June 2004, Journal of psychopharmacology (Oxford, England),
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
March 2002, Journal of psychopharmacology (Oxford, England),
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
September 2002, British journal of anaesthesia,
Christina R Maxwell, and Yuling Liang, and Bryanne D Weightman, and Stephen J Kanes, and Ted Abel, and Raquel E Gur, and Bruce I Turetsky, and Warren B Bilker, and Robert H Lenox, and Steven J Siegel
January 1999, Journal of psychopharmacology (Oxford, England),
Copied contents to your clipboard!